115 related articles for article (PubMed ID: 21214406)
21. [Treatment of advanced Wilms' tumor].
Li MJ; Huang Y; Tang DX; Zhou YB; Tang HF; Liang JF
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):791-5. PubMed ID: 17366799
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients.
Lin RY; Argenta PA; Sullivan KM; Adzick NS
Clin Cancer Res; 1995 Mar; 1(3):327-31. PubMed ID: 9815988
[TBL] [Abstract][Full Text] [Related]
23. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.
Metzger ML; Stewart CF; Freeman BB; Billups CA; Hoffer FA; Wu J; Coppes MJ; Grant R; Chintagumpala M; Mullen EA; Alvarado C; Daw NC; Dome JS
J Clin Oncol; 2007 Jul; 25(21):3130-6. PubMed ID: 17634492
[TBL] [Abstract][Full Text] [Related]
24. Relapse-associated variables in stage I favorable histology Wilms' tumor. A report of the National Wilms' Tumor Study.
Weeks DA; Beckwith JB; Luckey DW
Cancer; 1987 Sep; 60(6):1204-12. PubMed ID: 3040208
[TBL] [Abstract][Full Text] [Related]
25. Nephroblastoma: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells.
Camassei FD; Arancia G; Cianfriglia M; Bosman C; Francalanci P; Ravà L; Jenkner A; Donfrancesco A; Boldrini R
Am J Clin Pathol; 2002 Mar; 117(3):484-90. PubMed ID: 11888090
[TBL] [Abstract][Full Text] [Related]
26. Wilms' tumor: past, present and (possibly) future.
Spreafico F; Bellani FF
Expert Rev Anticancer Ther; 2006 Feb; 6(2):249-58. PubMed ID: 16445377
[TBL] [Abstract][Full Text] [Related]
27. The expression of HSP70 and HSP90alpha in children with Wilms tumor.
Yang Y; Niu ZB; Hou Y; Wang CL
J Pediatr Surg; 2006 Jun; 41(6):1062-6. PubMed ID: 16769335
[TBL] [Abstract][Full Text] [Related]
28. [Expression of the neurotrophin-receptor TrkB predicts outcome in nephroblastomas: results of a pilot-study].
Eggert A; Grotzer MA; Zhao H; Brodeur GM; Evans AE
Klin Padiatr; 2001; 213(4):191-6. PubMed ID: 11528553
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and outcome of Wilms tumors with a favorable histology in Japan: a report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
Suita S; Kinoshita Y; Tajiri T; Hara T; Tsuneyoshi M; Mizote H; Inada H; Takamatsu H; Kawano Y; Inomata Y; Nagasaki A; Ono Y; Handa N; Okamura J; Ishii E; Kawakami K;
J Pediatr Surg; 2006 Sep; 41(9):1501-5. PubMed ID: 16952581
[TBL] [Abstract][Full Text] [Related]
30. Outcome of relapses of nephroblastoma in patients registered in the SIOP/GPOH trials and studies.
Reinhard H; Schmidt A; Furtwängler R; Leuschner I; Rübe C; Von Schweinitz D; Zoubek A; Niggli F; Graf N
Oncol Rep; 2008 Aug; 20(2):463-7. PubMed ID: 18636212
[TBL] [Abstract][Full Text] [Related]
31. Clinical and biologic significance of nuclear unrest in Wilms tumor.
Hill DA; Shear TD; Liu T; Billups CA; Singh PK; Dome JS
Cancer; 2003 May; 97(9):2318-26. PubMed ID: 12712489
[TBL] [Abstract][Full Text] [Related]
32. Alpha-fetoprotein producing tumor cells in children with Wilms' tumor.
Kesik V; Ozcan A; Sari E; Guven A; Kismet E; Koseoglu V
Fetal Pediatr Pathol; 2010; 29(3):127-32. PubMed ID: 20450265
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic factors in Wilms' tumor].
Bezanilla JL; González Casaseca T
An Esp Pediatr; 1985 Aug; 23(2):125-9. PubMed ID: 2998250
[No Abstract] [Full Text] [Related]
34. Wilms' tumor: diagnosis and treatment in the 1990s.
Shochat SJ
Semin Pediatr Surg; 1993 Feb; 2(1):59-68. PubMed ID: 8062023
[TBL] [Abstract][Full Text] [Related]
35. C-kit protein expression in Wilms' tumour: an immunohistochemical study.
Giordano G; Campanini N; Rocco A; Donofrio V; Bertolini P; Falleti J; Pettinato G
Eur J Surg Oncol; 2009 Jun; 35(6):629-35. PubMed ID: 19010635
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study.
Grundy P; Breslow N; Green DM; Sharples K; Evans A; D'Angio GJ
J Clin Oncol; 1989 May; 7(5):638-47. PubMed ID: 2540289
[TBL] [Abstract][Full Text] [Related]
37. Der(16)t(1;16)(q21;q13) in Wilms' tumor: friend or foe.
Mathew P; Douglass EC; Jones D; Valentine M; Valentine V; Rowe S; Shapiro DN
Med Pediatr Oncol; 1996 Jul; 27(1):3-7. PubMed ID: 8614388
[TBL] [Abstract][Full Text] [Related]
38. The treatment of stages I-IV favorable histology Wilms' tumor.
Green DM
J Clin Oncol; 2004 Apr; 22(8):1366-72. PubMed ID: 15084612
[No Abstract] [Full Text] [Related]
39. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
[TBL] [Abstract][Full Text] [Related]
40. Histopathological variations among cases of Wilms' tumor in Bangladesh and its relationship with prognosis.
Ara T; Khan WA; Ali SM
Bangladesh Med Res Counc Bull; 1997 Aug; 23(2):56-9. PubMed ID: 9465437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
